IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10)

被引：0
|
作者：
M K Westman
J Pedersen-Bjergaard
M T Andersen
M K Andersen
机构：
[1] Section of Hematology/Oncology,Department of Clinical Genetics
[2] Rigshospitalet,undefined
[3] Copenhagen University Hospital,undefined
来源：
Leukemia | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：957 / 959
页数：2
相关论文
共 50 条
  • [11] IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
    Cerchione, Claudio
    Romano, Alessandra
    Daver, Naval
    DiNardo, Courtney
    Jabbour, Elias Joseph
    Konopleva, Marina
    Ravandi-Kashani, Farhad
    Kadia, Tapan
    Martelli, Maria Paola
    Isidori, Alessandro
    Martinelli, Giovanni
    Kantarjian, Hagop
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [12] IDH1 and IDH2 mutations in pediatric acute leukemia
    A K Andersson
    D W Miller
    J A Lynch
    A S Lemoff
    Z Cai
    S B Pounds
    I Radtke
    B Yan
    J D Schuetz
    J E Rubnitz
    R C Ribeiro
    S C Raimondi
    J Zhang
    C G Mullighan
    S A Shurtleff
    B A Schulman
    J R Downing
    Leukemia, 2011, 25 : 1570 - 1577
  • [13] IDH1 and IDH2 mutations in pediatric acute leukemia
    Andersson, A. K.
    Miller, D. W.
    Lynch, J. A.
    Lemoff, A. S.
    Cai, Z.
    Pounds, S. B.
    Radtke, I.
    Yan, B.
    Schuetz, J. D.
    Rubnitz, J. E.
    Ribeiro, R. C.
    Raimondi, S. C.
    Zhang, J.
    Mullighan, C. G.
    Shurtleff, S. A.
    Schulman, B. A.
    Downing, J. R.
    LEUKEMIA, 2011, 25 (10) : 1570 - 1577
  • [14] Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
    Issa, Ghayas C.
    DiNardo, Courtney D.
    BLOOD CANCER JOURNAL, 2021, 11 (06)
  • [15] Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
    Ghayas C. Issa
    Courtney D. DiNardo
    Blood Cancer Journal, 11
  • [16] Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia
    Wang, Jinghan
    Ma, Zhixin
    Wang, Qinrong
    Yu, Mengxia
    Yin, Xiufeng
    Li, Xia
    Suo, Shanshan
    Shen, Dan
    Wang, Yungui
    Huang, Xin
    Pan, Hanzhang
    Wang, Huanping
    Chen, Zhimei
    Huang, Jiansong
    Mao, Liping
    Yu, Wenjuan
    Wei, Juying
    Qian, Wenbin
    Mai, Wenyuan
    Meng, Haitao
    Tong, Hongyan
    Chen, Suning
    Marcucci, Guido
    Chen, Saijuan
    Jin, Jie
    BLOOD, 2016, 128 (22)
  • [17] Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients
    Aref, Salah
    Areida, El Sayed Kamel
    Aaal, Mohamed Fathy Abdel
    Adam, Ola Mohamed
    El-Ghonemy, Mohamed Sabry
    El-Baiomy, Mohamed Ali
    Abou Zeid, Tarek
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (09): : 550 - 555
  • [18] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions
    Wouters, Bas J.
    HEMASPHERE, 2021, 5 (06): : E583
  • [19] Myeloid neoplasms with der(1;7)(q10;p10)
    Okuda, Rurika
    Ochi, Yotaro
    Saiki, Ryunosuke
    Nakagawa, Masahiro M.
    Goto, Akihiko
    Atsuta, Yoshiko
    Shiraishi, Yuichi
    Mitani, Kinuko
    Chiba, Shigeru
    Takaori, Akifumi
    Miyano, Satoru
    Makishima, Hideki
    Nannya, Yasuhito
    Ogawa, Seishi
    CANCER SCIENCE, 2025, 116 : 122 - 122
  • [20] Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome
    Ishii, Yuko
    Hsiao, Hui-Hua
    Sashida, Goro
    Ioa, Yoshikazu
    Miyazawa, Keisuke
    Kodama, Atsushi
    Ohyashiki, Junko H.
    Ohyashiki, Kazuma
    CANCER GENETICS AND CYTOGENETICS, 2006, 167 (02) : 131 - 137
12345